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ABSTRACT
ickle cell anaemia, SCA, is a genetic disorder that 
results from a point mutation in the β-globin gene Sleading the production of haemoglobin S. The 
disease is prevalent in parts of Africa, the 
Mediterranean, Southeast Asia and Middle Eastern 
1regions of the world and mirrors the malaria belt.
Considerable variability has been observed in clinical 
manifestations as well as in laboratory parameters in 
individuals affected with this disease and this has 
2profound impact on survival.  Indeed, these clinical 
and laboratory parameters are increasingly reported as 
indices of disease severity. In various studies, the 
3frequency of vaso-occlusive crises, transfusion 
4 5 6requirement,  platelet  and the white cell counts    have 
been documented as markers of disease severity in 
SCD.
Blood pressure in individuals with SCA has been 
7,8known to be lower than in controls.  This has been 
explained from the standpoint of defective renal 
9concentrating ability with resultant hyposthenuria,  
10lower body mass index (BMI)  and reduced arterial 
11wall stiffness  found in this disease. Complications 
such as cerebrovascular accidents have been reported 
in individuals with SCA who have higher blood 
12pressures.  They have also been found to be at 
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 The corrected reticulocyte count was calculated using 
the formula;
An addition 5mls of venous blood anticoagulated in 
lithium heparin was used to obtain serum creatinine 
levels. A 24hr urine collection was used to estimate 
urinary creatinine concentrations and together serum 
and urinary creatinine were used to calculate creatinine 
clearance for subjects and controls (Jaffe's 
20methodology).
Statistical methods:
Statistical analysis was performed using SPSS version 
20 computer software (SPSS Inc.,
Chicago, IL, USA). Data was expressed using 
descriptive statistics such as percentages, means and 
standard deviations. The student's t-test was used to 
examine the relationship between blood pressure 
indices in SCA subjects and controls. Associations 
between parameters were tested using Pearson's linear 
regression for bivariate correlation The level of 
statistical difference was set at P ≤ 0.05.
Results:
The mean PCV of subjects in this study was 
25.39±6.77L/L, while it was 40.90±4.71L/L in controls. 
The mean ages of the subjects and controls were 
25.39±6.77 years and 25.66±4.77 years, respectively, 
there was no significant difference between them (P = 
0.79; Table 1). The mean crises frequency in subjects 
was 3.00±1.63 episodes in one year while 29 subjects 
(37%) were transfused at least once in the 2 years prior 
to recruitment.
The means of weight, BSA and BMI were lower in 
subjects than controls (49.39±9.01 kg and 61.04±10.24 
kg; 1.45±0.16 and 1.65±0.15; and 18.31±2.48 and 
23.27±2.55, respectively. These differences were 
statistically significant (P = 0.01, respectively; Table 1). 
There was no significant difference in the height of 
subjects when compared with controls (1.64±0.01m and 
1.62±0.11m respectively;  P = 0.25; Table 1).
The means of systolic and diastolic blood pressures in 
subjects and controls were 105.52±11.75mmHg and 
113.20±7.94mmHg; and 62.59±9.33mmHg and 
75.40±5.70mmHg respectively (Table 2). There were 
significant differences in the systolic and diastolic 
blood pressures of subjects and controls, P =0.01 and 
0.03, respectively (Table 2). The means of pulse 
pressure (PP) and mean arterial pressure (MAP) in 
subjects and controls were 42.92±10.91mmHg and 
increased risk of developing ventricular diastolic 
dysfunction, which is an independent predictor of 
12,13disease mortality.  Interestingly, some of these 
complications were reported to occur at blood pressure 
14ranges considered conventionally normal.  These 
observations have increasingly supported the 
speculation that hypertension in individuals with SCA 
may  occur at a lower blood pressure than is expected 
15for individuals with Hb AA.  The purpose of this study 
was to evaluate the relationship between blood 
pressure indices in Nigerians with SCA and some 




Seventy-nine (79) known SCA patients that regularly 
attended the follow–up clinic at the Haematology Out-
patient department of our hospital were studied over a 
7-month period. They were recruited while in steady 
state (clinically stable in the preceding three weeks and 
had not received blood transfusion in the preceding 
16three months),  with no clinical features suggestive of 
congestive heart failure. Controls were 50 apparently 
healthy Hb AA medical and nursing students, age-
matched with study subjects. Ethical approval was 
obtained from the Ethics and Research Committee of 
our hospital and all participants gave informed 
consent.
Clinical and Laboratory Measurements:
The number of major crises episodes in the last one year 
and the frequency of blood transfusions in the last two 
years were recorded in a case record form for all 
subjects. A 24-hour urine collection, for creatinine 
clearance determination was obtained from subjects 
and controls. Clinical parameters such as height, 
weight and blood pressure were measured and 
recorded for all participants. Sitting blood pressure 
w a s  o b t a i n e d  a t  r e s t ,  u s i n g  m e r c u r y  
sphygmomanometer. The systolic and diastolic blood 
pressures were reported as the first and fifth korotkoff 
17sounds respectively,  while the mean arterial blood 
pressure (MAP) was calculated from the sum of the 
diastolic blood pressure and one-third of the pulse 
pressure. Body surface area (BSA) was calculated with 
18the Mostella formula,  while body mass index (BMI) 
was calculated using the formula;                  
                                                    Weight
2                                                    Height   
                                                                                                                                                                 
Five milliliter (5mls) of venous blood, anticoagulated in 
EDTA was obtained from subjects and controls to 
obtain a full blood count (FBC) using a Sysmex (KN-21) 
automated analyzer while the reticulocyte count was 
19obtained following standard operating procedures.  
Observed Reticulocyte (%)  x  Measured Packed Cell Volume (PCV)
Appropriate Normal Packed Cell Volume (PCV) 
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the severity of anaemia; this has led to the conclusion 
15that individuals with SCA have relative hypertension.   
A number of earlier studies had documented lower 
systolic and diastolic blood pressures, including MAP 
7,10,26,28in patients with SCA, compared with controls.  
Our finding corroborated the above studies; systolic 
and diastolic blood pressures were significantly lower 
in individuals with SCA, compared with controls (p 
values 0.01 and 0.03, respectively, Table 2). In contrast, 
Oguanobi et al studied 62 individuals with SCA in 
Enugu, south-east, Nigeria and showed that the 
systolic blood pressure was not significantly different 
when compared with controls (119.59±11.70 mmHg 
29and 121.20±8.97 mmHg, respectively, P = 0.60).  
Similarly, Akinola et al had earlier noted that the mean 
resting systolic blood pressures in individuals with 
SCA were within normal limits and were not different 
30from control values.  The reasons for this discrepancies 
were not entirely clear from this study, however we 
observed that the subjects (particularly) in the Enugu 
study differed slightly from ours with regards to age, 
weight and PCV (28.27±5.58 years vs. 25.39±6.77 years, 
54.97±10.61kg vs. 49.39±9.01kg and 24.07±3.10L/L vs. 
23.90±4.30L/L, respectively). These are indices that are 
known to have negative and positive influences on the 
blood pressure.  
The pulse pressure was significantly higher and the 
MAP significantly lower in individuals with SCA when 
compared with controls, in a similar study in Enugu, 
2 9Nigeria.  This has been attributed to the 
haemodynamic changes of chronic anaemia, coupled 
with the increased background inflammatory and 
31oxidative stress associated with the disease.  These 
combine to reduce left ventricular after load as well as 
blood viscosity, with a resultant decrease in arteriolar 
32tone.  The findings of the present study confirmed the 
above observation (P =0.04, Table 2) when individuals 
with SCA were compared with controls.
A significant correlation was observed between the age 
of male individuals with SCA and systolic and diastolic 
blood pressures (Table 3). The effect of age on blood 
pressure (and its indices) in SCA has been a subject of 
diverse opinion. This study agrees with the reports of 
12 17Rodgers et al,  Pegelow et al,  and Adams-Campbell et 
32 7 28 29al,   while Johnson et al,  Grell et al,   Oguanobi et al,  
 30and Akinola et al  did not document any correlation 
between age and blood pressure and argue that 
individuals with SCA fail to show the expected rise in 
blood pressure with age probably because of impaired 
renal handling of potassium and sodium, which tends 
to worsen with age.
In female individuals with SCA it was observed that a 
significant inverse correlation existed between white 
37.80±7.43mmHg; and 76.90±8.81mmHg and 
88.00±5.51mmHg respectively (Table 2). The 
differences in the PP and MAP of subjects and controls 
were significant (P = 0.03 and 0.04 respectively; Table 
2).
In male subjects age correlated with systolic and 
diastolic blood pressures (r = 0.44; P = 0.01 and r = 0.39;  
P = 0.02 respectively; Table 3) while in female subjects, 
the white cell count correlated with systolic blood 
pressure (r = -0.39;  P = 0.01) and PP (r = -0.33;  P = 0.03; 
Table 4).
In male controls, the haematocrit was correlated with 
PP (r = -0.43;  P = 0.02) while body mass index 
correlated with systolic blood pressure (r = 0.39; P = 
0.03; Table 5).  In female controls the diastolic and mean 
arterial pressures were positively correlated with age (r 
= 0.55; P = 0.01 and r = 0.49;  P = 0.02, respectively) and 
negatively corrected with the corrected reticulocyte 
count (r = -0.61;  P = 0.01 and r = -0.62;  P = 0.01 
respectively), Table 6. 
DISCUSSION:
The controls in this study were matched for age with 
the subjects, as evidenced by the lack of statistical 
difference in the age distribution of subjects when 
compared to controls (Table 1).
Historically, individuals with SCA have been 
characterized by a number of unique physical 
attributes which have been collectively described as 
sickle cell habitus or facies, these include some 
21,22craniofacial features and low BMI.  The later is said to 
be as a result of the increased resting energy 
expenditure caused by exacerbated erythropoietic and 
22cardiac activities.  This study corroborated this 
observation with the weight, BSA and BMI  being 
significantly lower in subjects compared to controls (P 
= 0.01 respectively; Table 1).  On the contrary however, 
recent studies have reported obesity in individuals 
with SCD most probably due to better disease 
24,25 management in more developed countries. 
Sickle cell anaemia is associated with varying degrees 
of anaemia; this is largely due to chronic red cell 
26haemolysis that occurs, even in the steady state.  
Anaemia has a profound effect on the cardiovascular 
17system that worsens with increasing severity.  In 
particular, both systolic and diastolic blood pressures 
have been found to be lower than expected in patients 
26with anaemia.  Conversely, individuals with SCA  
with high PCV have been associated with increased 
blood viscosity, vascular endothelial dysfunction and 
27hypertension.  Even in anaemic patients, the blood 
pressure has been found to be higher than expected for 
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endothelial function and pulse wave velocity (PWV). 
Increased PWV has been associated with subclinical 
37organ dysfunction.
The work of Laurent et al noted that progressive 
arterial wall stiffness was linked to age-dependent 
vascular damage, in non-SCD subjects, while Demirci 
et al observed that worsening arterial wall stiffness was 
38,39most related to high MAP.  This study recorded a 
variable relationship between blood pressure indices 
and age in the non SCD subjects; while it was positively 
correlated with diastolic and mean arterial pressures in 
females, (r = 0.55; P = 0.01 and r = 0.49; P =0.02, 
respectively, Table 6) no similar relationship was 
observed in males, the reason for this was not apparent 
from this study.
CONCLUSION
Blood pressure indices varied significantly in 
individuals with SCA when compared with apparently 
healthy controls and variations were related with 
advancing age in males and white cell count in females. 
Monitoring of the blood pressure in individuals with 
SCA may thus be useful in determining those with 
severe disease, particularly among the females. 
blood cell count and systolic and pulse pressures (Table 
4). The role of white blood cells in the pathogenesis of 
SCA, including its usefulness as a marker of disease 
6,33severity has been variously documented.  This makes 
the observation in this study that shows a negative 
relationship between white cells and systolic blood 
pressure even more interesting. The earlier report of 
34Desai et al  in a cohort of individuals with SCD in the 
United States is confirmed by this present study. It is 
believed that the physiologic effects of hypoxia from 
hypotension (and low  haematocrit of SCD) may lead to 
a number acute anaemic events (AAEs) and acute 
phase response which could be reflected by an 
35increased WBC and other reactants.  In the 
INTERSALT study, Dyer et al reported that the weight 
in apparently healthy (non-SCD) individuals 
correlated significantly with the blood pressure and 
concluded that weight (adjusted for height) may be a 
good analysis of the association of adiposity with blood 
36 pressure in apparently healthy individuals. This was 
confirmed in male control in this study where a 
significant positive correlation between BMI and 
systolic blood pressure (r = 0.39; p = 0.03; Table 5) was 
observed. Similarly, male controls showed a significant 
negative correlation between haematocrit and pulse 
pressure (r = -0.43;  P = 0.02; Table 5). This may be due to 
the influence of haematocrit on blood viscosity, 
Table 1: Comparison of Demographic and Anthropometric Data in SCA and Control subjects.  
Parameters HB SS 
Mean (SD) 
n = 79 
Controls 
Mean (SD) 
n = 50 
 
t – Test  P-Value 
Age (years) 25.39 (6.77) 25.66 (4.77) -0.26 0.79 
Weight (kg) 49.39 (9.01) 61.04 (10.24) -6.79 *0.01 
Height (m) 1.64 (0.01) 1.62 (0.11) 1.16 0.25 
Body Surface Area (m2) 1.45 (0.16) 1.65 (0.15) -7.00 *0.01 
Body Mass Index (kg/m2) 18.31 (2.48) 23.27 (2.55) -10.94 * 0.01 
*significant p values.
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Table 4: Correlation Analysis for Female SCA subjects; Blood pressure indices with clinical 












































































































































































Nigerian Journal of Medicine, Vol. 25 No. 1, January - March, 2016, ISSN 1115-2613
65
 
Table 5: Correlation Analysis for Controls (Male); Blood pressure indices with clinical and laboratory 
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Table 6: Correlation Analysis for Controls (Female); Blood pressure indices with clinical and laboratory 
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